UniProt Q93UV0
Q93UV0
Q93UV0 (UniProt Q93UV0): 18 experimental structures on GenesisL1. Binding sites, pockets, druggability and 3D structures in GL1X.
- UniProt
- Q93UV0
- Experimental structures
- 18
- Predicted models
- 0
Structures
18 records of Q93UV0 in the MolNFT archive: 18 experimental, 0 predicted.
| Entry | Title | Method | Chains | Ligands | Pockets |
|---|---|---|---|---|---|
| 2JG2 | High resolution structure of spt with plp internal aldimine | x-ray diffraction | A | — | — |
| 2JG2 | High resolution structure of spt with plp internal aldimine | x-ray diffraction | A | — | — |
| 2JGT | Low resolution structure of SPT | x-ray diffraction | A, B | — | — |
| 2JGT | Low resolution structure of spt | x-ray diffraction | A, B | — | — |
| 2W8J | SPT with PLP-ser | x-ray diffraction | A | — | — |
| 2W8J | Spt with plp-ser | x-ray diffraction | A | — | — |
| 2W8T | SPT with PLP, N100C | x-ray diffraction | A | — | — |
| 2W8T | Spt with plp, N100C | x-ray diffraction | A | — | — |
| 2W8U | SPT with PLP, N100Y | x-ray diffraction | A | — | — |
| 2W8U | Spt with plp, N100Y | x-ray diffraction | A | — | — |
| 2W8V | SPT with PLP, N100W | x-ray diffraction | A | — | — |
| 2W8V | Spt with plp, N100W | x-ray diffraction | A | — | — |
| 2W8W | N100Y SPT with PLP-ser | x-ray diffraction | A | — | — |
| 2W8W | N100Y spt with plp-ser | x-ray diffraction | A | — | — |
| 2XBN | Inhibition of the PLP-dependent enzyme serine palmitoyltransferase by cycloserine: evidence for a… | x-ray diffraction | A | — | — |
| 2XBN | Inhibition of the plp-dependent enzyme serine palmitoyltransferase by cycloserine: evidence for a… | x-ray diffraction | A | — | — |
| 4BMK | Serine Palmitoyltransferase K265A from S. paucimobilis with bound PLP- Myriocin Aldimine | x-ray diffraction | A, B | — | — |
| 4BMK | Serine palmitoyltransferase K265A from S. paucimobilis with bound plp-myriocin aldimine | x-ray diffraction | A, B | — | — |
Elsewhere
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.